Background: We assessed associations between intraoperative neuraxial block and postoperative epidural analgesia, and a composite primary outcome of death or non-fatal myocardial infarction, at 30 days post-randomization in POISE-2 Trial subjects. Methods: 10 010 high-risk noncardiac surgical patients were randomized aspirin or placebo and clonidine or placebo. Neuraxial block was defined as intraoperative spinal anaesthesia, or thoracic or lumbar epidural anaesthesia. Postoperative epidural
• The interaction between neuraxial anaesthesia or analgesia and a primary outcome of death or nonfatal myocardial infarction was studied.
• In a subanalysis of the POISE-2 Trial, neuraxial anaesthesia or postoperative epidural analgesia was not associated with death, myocardial infraction or stroke in high-risk noncardiac surgery subjects, in contrast to findings from the POISE-1 Trial.
• Neuraxial anaesthesia was associated with less hypotension than general anaesthesia.
• Additional large randomized controlled trials of the impact of anaesthetic technique on cardiovascular outcome are necessary.
The effects of intraoperative neuraxial block and postoperative epidural analgesia on major cardiovascular outcomes after noncardiac surgery remain controversial. [1] [2] [3] [4] No large randomized controlled trial in at-risk patients focused on cardiovascular morbidity and mortality has been published in the last decade 5 6 and no trial is registered with major clinical trials registries worldwide. [7] [8] [9] [10] [11] Systematic reviews continue to summarize the results of small and heterogeneous studies. 12 Post hoc analyses of large multi-centre randomized controlled trials of other interventions, in which large numbers of patients at high risk of adverse cardiovascular outcomes received intraoperative neuraxial block or postoperative epidural analgesia, therefore remain one of the options for exploring this controversy. 13 14 In such an analysis of the POISE-1 Trial subjects we reported that neuraxial block was associated with increased odds of the composite primary outcome (cardiovascular death, nonfatal myocardial infarction and nonfatal cardiac arrest) and secondary outcome of myocardial infarction. 13 The POISE-2 Trial presents another such opportunity. In POISE-2, 10 010 noncardiac surgery patients at risk of cardiovascular complications were randomized using a factorial design to aspirin or placebo and clonidine or placebo, and were followed for 30 days for a composite primary outcome of death or nonfatal myocardial infarction. 15 Many subjects had surgery under neuraxial block, with or without general anaesthesia, and received postoperative epidural analgesia. A pre-specified subgroup analysis of the main study revealed a significant interaction (P=0.01) between clonidine treatment and neuraxial block: clonidine was associated with increased risk of the primary outcome in subjects who did not receive neuraxial block [hazard ratio, 1.30; 95% confidence interval (CI), 1.05-1.60] but not in subjects who did receive neuraxial block (hazard ratio, 0.89; 95% CI, 0.58-1.38). 16 This effect was counter to the direction of our a priori hypothesis, but was not adjusted for potentially confounding factors.
The primary aim of the current post hoc study was to determine the relationship between intraoperative neuraxial block or postoperative epidural analgesia and the primary outcome within 30 days of randomization in the POISE-2 Trial. Secondary aims included further exploration of the apparent interaction between clonidine and intraoperative neuraxial block with respect to the primary outcome.
Methods
The POISE-2 Trial protocol was registered with ClinicalTrials.gov (NCT00182874) and the main results have been published. 16 17 The trial was multi-centred, blinded, randomized and placebocontrolled. Patients were recruited if they were aged ≥45 yr, were undergoing noncardiac surgery and fulfilled at least one of the following criteria: history of coronary artery disease, peripheral vascular disease, stroke, planned major vascular surgery or any three of nine cardiovascular risk criteria. Patients were excluded if they had a contraindication to administration of aspirin or clonidine or had a bare-metal stent inserted <six weeks or drug-eluting coronary stent inserted <one yr before randomization. Patients taking aspirin chronically had to stop it at least 72 h before surgery to be eligible. Ethics committee approval was obtained at all centres and written consent was provided by all subjects.
In POISE-2, aspirin (200 mg) or placebo was administered preoperatively and for 30 days (in aspirin-naïve subjects) or seven days (in subjects who had been taking aspirin chronically before randomization) at a 100 mg dose. Clonidine (0.2 mg) or placebo was administered preoperatively and was continued for three days. Troponin or creatine kinase-myocardial band assays were monitored during the first three days after surgery. The primary outcome was a composite of death or nonfatal myocardial infarction within 30 days of randomization. Secondary outcomes included death, myocardial infarction, stroke and clinically important hypotension, which was defined as a systolic arterial pressure of <90 mm Hg recorded at least once any time in the study period and requiring treatment or study drug discontinuation.
The current analysis was designed and executed post hoc, according to a statistical analysis plan that was prospectively approved by the POISE-2 Trial Publications Committee. Neuraxial block was defined as intraoperative administration of spinal anaesthesia, or thoracic or lumbar epidural anaesthesia, with or without general anaesthesia or nerve block. Postoperative epidural analgesia was defined as postoperative administration of epidural local anaesthetic and/or opioid. No further data about the decision to use neuraxial block and/or postoperative epidural analgesia or the details of these techniques were recorded in the POISE-2 Trial.
Data analysis
Baseline characteristics were summarized as mean () or (range) for continuous variables and number (%) for categorical variables. Groups were compared using analysis of variance and χ 2 tests, respectively.
Neuraxial block and postoperative epidural analgesia were not randomly assigned in the POISE-2 Trial. An inverse probability of treatment weighting technique therefore was used to reduce the bias of these nonrandomized treatment comparisons. Similar methods were used in our post hoc analysis of the POISE-1 Trial. 13 The inverse probability of treatment weighting approach is one of a class of methods known as propensity score methods. 18 The unifying property of these methods is that the estimated probability that each patient will receive the intervention (the propensity score), is used to obtain a sample in which characteristics are balanced between the treatment groups. In contrast to data from randomized trials, balance is only possible for the covariates that are included in the model used to estimate the propensity score. The covariate of participating countries was handled through grouping the 23 countries into the following regions recruiting >10% of the patients each: 1) Canada; 2) USA; 3) Central and South America; 4) Europe; 5) South Africa, Pakistan, India and Malaysia, and 6) Hong Kong and Australia.
Balance of characteristics between groups was assessed using standardized differences (the difference between the percentage/ mean between groups, divided by the standard deviation). 19 The standardized difference is expressed as a percentage, and characteristics with absolute values ≥10% are considered to represent a meaningful imbalance between groups. 20 Propensity score approaches assume that each patient has a positive probability of both receiving the intervention and not receiving the intervention (known as the positivity assumption), leading to our exclusion of spinal surgery patients from all comparisons in this analysis, as they were not eligible for neuraxial block. For each of the treatment comparisons, groups in which none or few of the patients received the intervention, were excluded to satisfy the positivity assumption. Patients with multiple or unknown types of neuraxial block, patients having surgery under local anaesthesia only and patients having more than one type of surgery were excluded from all analyses. Logistic models for each intervention dependent on baseline characteristics, were used to estimate propensity scores. Following standard recommendations, 19 logistic regression models were selected iteratively, by first including all baseline characteristics, assessing the balance between groups using standardized differences, then including interaction terms as appropriate, until no further imbalance could be removed. The development occurred without reference to the outcome variables. The 'common support' condition, implied by the positivity assumption, 21 states that in each treatment group there must be comparable subjects in the other treatment group. 22 Subjects in each treatment group that do not have subjects in the other group with similar propensity scores are thus in violation of this condition and were excluded from analyses. For example, for the neuraxial block comparison, those patients receiving neuraxial block with higher propensity scores than any subjects not receiving neuraxial block were excluded, as were subjects who did not receive neuraxial block with a lower propensity score than that of any subject who did receive neuraxial block. In this way, subjects in each neuraxial block treatment group without a comparable counterpart in the other group were excluded from analyses. This process ensured that the analysis only included neuraxial block subjects who were most similar to the no neuraxial block subjects. The common support condition was applied to all neuraxial and postoperative epidural analgesia analyses.
To estimate the association with the treatment for the primary outcome, death, myocardial infarction, stroke and clinically important hypotension, each subject was weighted by the inverse of the probability of receiving the treatment they actually received, and the logistic regression model for the outcome was fitted with the treatment as the sole predictor, with odds ratios (OR) and 95% CIs for the effect of treatment estimated. If any covariates remained unbalanced between the two groups, these were included as additional covariates in additional regression models.
To assess the sensitivity of estimates to extreme inverse probability of treatment weights, for each comparison, weights were truncated at the 1st and 99th percentiles, and outcome regression models were estimated again.
To assess the interaction of neuraxial block and clonidine, adjusted ORs for clonidine were estimated in subjects receiving and not receiving neuraxial block.
Secondary analyses were undertaken to assess the impact of the following interventions: general anaesthesia alone vs spinal anaesthesia alone (as few subjects received spinal anaesthesia combined with general anaesthesia); general anaesthesia alone vs thoracic epidural combined with general anaesthesia (as few subjects received thoracic epidural alone); general anaesthesia alone vs lumbar epidural with or without general anaesthesia (as too few subjects had lumbar epidural to allow separate comparisons with or without general anaesthesia); no postoperative epidural analgesia vs postoperative epidural analgesia; and postoperative epidural opioid alone vs postoperative local anaesthetic with or without opioid.
All analyses were conducted using Stata version 12 (Stata Corporation, College Station, TX, USA) Statistical significance was ascribed at P<0.05.
Results
In total 8924 subjects were included in the neuraxial block analysis and 2827 subjects were included in the postoperative epidural analgesia analysis. The reasons for exclusions from the analyses are outlined in Table 1 .
Neuraxial block was administered to 3986 (45%) of the 8924 subjects who were included in the neuraxial block analysis. These subjects were more likely to be male and to be presenting for vascular or orthopaedic surgery than subjects not receiving neuraxial block (Table 2 ). There were differences in the percentages of included subjects receiving neuraxial block in different regions (Canada=62%, USA=27%, Europe=41%, Central and South America=31%, South Africa/Pakistan/India/Malaysia=47%, Hong Kong and Australia=26%). Baseline imbalances between intervention groups were reduced to acceptable levels by propensity score weighting and exclusion of subjects to ensure satisfaction of the common support assumption. Weighting also reduced imbalance with respect to the spinal anaesthesia and thoracic Tables S1-S3) . Postoperative epidural analgesia was administered to 893 (32%) of the 2827 subjects who were included in the postoperative epidural analgesia analysis. These subjects were more likely to be male and less likely to be presenting for orthopaedic surgery than subjects not receiving postoperative epidural analgesia (Table 3 ). There were differences in the percentages of included subjects receiving postoperative epidural analgesia in different regions (Canada=24%, USA=50%, Europe=49%, Central and South America=38%, South Africa/Pakistan/India/Malaysia=16%, Hong Kong and Australia=37%). Baseline imbalances between postoperative epidural analgesia and no postoperative epidural analgesia subjects were reduced by propensity score weighting, however a number of variables remained imbalanced (absolute value of standardized differences >10%). Weighting reduced imbalance to acceptable levels between postoperative epidural local anaesthetic with or with opioid and postoperative epidural opioid alone (Supplementary material, Table S4 ).
Neuraxial block was not associated with the primary outcome (OR, 0.89; 95% CI, 0.73-1.08; P=0.24), death (OR, 0.84; 95% CI, 0.53-1.35; P=0.48), myocardial infarction (OR, 0.91; 95% CI, 0.74-1.12; P=0.36) or stroke (OR, 1.05; 95% CI, 0.44-2.49; P=0.91). The odds of an association between neuraxial block and clinically important hypotension was 0.90 (95% CI, 0.81-1.00; P=0.04) ( Table 4 ). The odds of the primary outcome in clonidine-treated patients not having neuraxial block was 0.91 (95% CI, 0.70-1.19) and in clonidine-treated patients having neuraxial block was 1.28 (95% CI, 0.96-1.71) (P value for interaction=0.087) ( Table 5) .
Spinal anaesthesia alone was associated with lower odds of the primary outcome (OR, 0.44; 95% CI, 0.33-0.57; P<0.001), death (OR, 0.41; 95% CI, 0.19-0.86; P=0.02), myocardial infarction (OR, 0.46; 95% CI, 0.35-0.60; P<0.001) and clinically important hypotension (OR, 0.37; 95% CI, 0.32-0.43; P<0.001) than general anaesthesia alone. Thoracic epidural combined with general anaesthesia was associated with greater odds of clinically important hypotension than general anaesthesia alone (OR, 2.06; 95% CI, 1.60-2.66; P<0.001). There were no statistically significant associations with any of the outcomes in the lumbar epidural analyses (Table 4) .
Postoperative epidural analgesia was not associated with a significant effect on the primary outcome (OR, Tables S5  and S6 ).
Discussion
The principal result of these post hoc analyses was that neuraxial block and postoperative epidural analgesia were not associated with the primary outcome, death, myocardial infarction or stroke. However our sub-analyses suggest that there may be a difference between spinal anaesthesia and thoracic epidural anaesthesia with respect to adverse outcomes that could be explored 3 14 The current analysis adds to previous reports, supporting the view that neuraxial block does not alter cardiovascular outcomes and that the decision to use neuraxial block should be based on other criteria. 5 6 12 23 24 None of the available evidence is definitive. The largest randomized trials (Park and colleagues, 5, 6 n=1021; the MASTER trial, n=915) were underpowered for death and myocardial infarction. Systematic reviews necessarily summarize small studies, many are of inferior quality and conducted decades ago, 12 23 25-27 and concern is mounting about the risk of type 1 error from repeated testing. 28 Large retrospective studies 24 29 30 and post hoc analyses of large randomized trials of other interventions 13 provide high numbers of events but are limited by the methods available to minimize bias. 14 31-34 Despite this lack of definitive evidence, many anaesthetists still believe that neuraxial block represents a useful intervention to reduce perioperative mortality. 1 We conducted a similar post hoc analysis of the POISE-1 Trial that randomized patients to metoprolol or placebo. 13 35 In that analysis, neuraxial block was associated with increased odds of the primary outcome (cardiovascular death, non-fatal myocardial infarction and non-fatal cardiac arrest) (OR, 1.24; 95% CI, 1.02-1.49) and myocardial infarction (OR, 1.32; 95% CI, 1.07-1.64). The POISE-1 and POISE-2 sub-analyses included similar numbers of subjects receiving neuraxial block (n=3909 and n=3986, respectively). The baseline covariates available for propensity score development and details of neuraxial block were similar in the two studies. Although POISE-1 randomized more men; more subjects having vascular surgery; and more subjects with coronary artery disease and peripheral vascular disease than POISE-2, event rates were similar. 16 35 We conclude that the differences in results might result from random error. We urged cautious interpretation of our initial finding of an interaction between clonidine and neuraxial block with respect to the primary outcome because it was counter to the direction of our a priori hypothesis. 16 Supporting this, after excluding patient groups for whom neuraxial block was not an option and adjusting for baseline variables related to the decision to use neuraxial block, we found no significant interaction. The reversal of the original direction of effect 16 in the current analyses further supports our conclusion of no significant interaction between clonidine and neuraxial block. Our secondary analyses suggested that spinal anaesthesia was associated with lower odds of the primary outcome, death, myocardial infarction and clinically important hypotension than general anaesthesia. Lower odds of adverse outcomes in the spinal anaesthesia group were also demonstrated in post hoc analyses of the POISE-1 Trial, although in that case statistical significance was not reached. 13 Our results are consistent with a recent observational study in hip fracture patients, 30 but inconsistent with systematic reviews that do not support a difference in cardiovascular outcomes after hip fracture surgery, 27 total hip arthroplasty 36 or lower limb orthopaedic surgery. 37 However, none of these studies differentiated between spinal and epidural anaesthesia. Our secondary analyses also suggested that thoracic epidural with general anaesthesia was associated with greater odds of clinically important hypotension than general anaesthesia alone. This result is consistent with our POISE-1 analysis 13 and a previous systematic review. 38 As clinically important hypotension was independently associated with myocardial infarction in the main POISE-2 analysis, prevention and/or treatment of clinically important hypotension in patients having operations where thoracic epidural, is an option that must be a significant focus for future work. We did not replicate our finding from POISE-1 where thoracic epidural with general anaesthesia was associated with higher odds of the primary outcome or myocardial infarction than general anaesthesia alone. 13 This may be as a result of a type I error. These sub-analyses suggest that neuraxial block should not be considered a homogeneous intervention. This argument is supported by our pre-specified plan to explore the effects of three neuraxial techniques in the same analysis, the consistency of these results with our POISE-1 analysis 13 and by the differential effect of the two techniques on the risk of clinically important hypotension (decreased for spinal anaesthesia and increased for thoracic epidural anaesthesia). On the other hand, the well-established and repeatedly-demonstrated danger of drawing firm conclusions from sub-group analyses (of post hoc analyses) must be recognized. 39 It should also be noted though that general anaesthesia was administered to thoracic epidural patients but not spinal anaesthesia patients and the effect of this is uncertain. Postoperative epidural analgesia was not associated with altered cardiovascular outcomes, although postoperative epidural analgesia with local anaesthetic, with or without opioid, was associated with more clinically important hypotension than postoperative epidural opioid alone. A systematic review of randomized trials of postoperative epidural analgesia with local anaesthetics, opioids or both compared with systemic opioids in aortic surgery patients, concluded that myocardial infarction risk was reduced but mortality risk was unchanged by postoperative epidural analgesia. 40 However, comparable reviews in hip and knee joint replacement 41 and open abdominal surgery 42 patients found no evidence for effects on cardiovascular outcomes, although hypotension was more common in patients receiving epidural analgesia in the orthopaedic review. 41 Hypotension resulting from sympathetic nervous system block is a well-known effect of epidural local anaesthetic, 41 43 and might be mechanistically linked to adverse postoperative outcomes and could have implications for the appropriate venue for postoperative care in these patients. This analysis has strengths and limitations. The analysis included more subjects than previous randomized controlled trials 5 6 and systematic reviews. 12 37 40 41 Patients were at high risk of adverse cardiovascular events and were monitored closely for predefined efficacy and safety outcomes in a clinical trial context. The quality and fidelity of our data minimizes ascertainment bias, misclassification of important variables and missing data. The size of the database allows a precision of effect-size estimates not usually possible outside of administrative megadatabases; however, administrative data frequently suffers from ascertainment bias and misclassification of covariates. Our analyses have limitations, many of which are shared by our analysis of POISE-1 Trial subjects, 4 13 14 and other observational studies. The POISE-2 Trial was designed to test hypotheses about the randomized interventions and not neuraxial block and postoperative epidural analgesia. We did not record the reasons for choosing neuraxial block or postoperative epidural analgesia over other techniques, and it is clear from regional variations that local preferences exist. The broad classification of surgery type in POISE-2 meant that exclusion of subjects who were ineligible for the interventions might have been inaccurate. Propensity methods were applied in an attempt to ameliorate these issues, 19 however these methods do not create baseline equality with respect to unmeasured or unknown confounders, and we had difficulty with residual baseline imbalance of known confounders in several sub-groups. We have little data on the details of the anaesthetic and postoperative analgesic techniques used: the quality and extent of anaesthesia and postoperative analgesia in the neuraxial or postoperative epidural patients and their comparator groups is likely to be important. 2 Neuraxial block and postoperative epidural analgesia might have influenced other aspects of care, such as haemodynamic and antiplatelet agent/ anticoagulant management, the conduct of general anaesthesia and the use of plexus and nerve blocks, however we have no information of these aspects of care. We made an a priori decision to limit our analyses to the cardiovascular outcomes that were considered in our POISE-1 analysis, 13 as these were the focus of the POISE-2 Trial as well. 16 17 Respiratory outcomes associated with increased mortality such as pneumonia and the need for postoperative mechanical ventilation were not specifically assessed in the POISE-2 Trial 16 17 and likely affect overall outcomes. 38 Finally the sample size available for this analysis did not allow us to rule out smaller, but still potentially clinically meaningful, differences in outcomes according to anaesthesia type. The confidence intervals around our estimates of effects demonstrate that our analyses have not ruled out potentially clinically meaningful differences in outcomes according to anaesthesia type. Papers about neuraxial block and postoperative epidural analgesia typically conclude with a call for more randomized controlled trial evidence. 12 A suite of trials in high-risk patients having common operations often managed with these techniques, and associated with significant postoperative pain and adverse outcomes, will therefore be required.
In conclusion, intraoperative neuraxial block and postoperative epidural analgesia were not associated with altered odds of adverse cardiovascular outcomes in high-risk noncardiac surgery patients participating in the POISE-2 Trial, and there was no significant interaction between clonidine and neuraxial block. These findings contrast with the results of our post hoc analysis of the POISE-1 Trial. The effect of these techniques on adverse cardiovascular outcomes remains unresolved and large randomized controlled trials are required. 
